Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 11, 2015 - Issue
Submit an article Journal homepage
326
Views
51
CrossRef citations to date
0
Altmetric
Review

Rare and very rare adverse effects of clozapine

Pasquale De Fazio1 Department of Health Sciences, School of Specialization in Psychiatry, University “Magna Graecia”, Catanzaro, ItalyCorrespondence[email protected]
,
Raffaele Gaetano1 Department of Health Sciences, School of Specialization in Psychiatry, University “Magna Graecia”, Catanzaro, Italy
,
Mariarita Caroleo1 Department of Health Sciences, School of Specialization in Psychiatry, University “Magna Graecia”, Catanzaro, Italy
,
Gregorio Cerminara1 Department of Health Sciences, School of Specialization in Psychiatry, University “Magna Graecia”, Catanzaro, Italy
,
Francesca Maida2 Department of Health Sciences, School of Specialization in Pharmacology, University “Magna Graecia”, Catanzaro, Italy
,
Antonio Bruno3 Department of Neurosciences, School of Specialization in Psychiatry, University of Messina, Messina, Italy
,
Maria Rosaria Muscatello3 Department of Neurosciences, School of Specialization in Psychiatry, University of Messina, Messina, Italy
,
Maria Jose Jaén Moreno4 Department of Social Health Sciences, Radiology and Physical Medicine, University of Cordoba, Cordoba, Spain
,
Emilio Russo2 Department of Health Sciences, School of Specialization in Pharmacology, University “Magna Graecia”, Catanzaro, Italy
&
Cristina Segura-García1 Department of Health Sciences, School of Specialization in Psychiatry, University “Magna Graecia”, Catanzaro, Italy
 show all
Pages 1995-2003 | Published online: 06 Aug 2015

Citations (51)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Tommaso B. Jannini, Andrea Sansone, Rodolfo Rossi, Giorgio Di Lorenzo, Massimiliano Toscano, Alberto Siracusano & Emmanuele A. Jannini. (2022) Pharmacological strategies for sexual recovery in men undergoing antipsychotic treatment. Expert Opinion on Pharmacotherapy 23:9, pages 1065-1080.
Read now
Renato de Filippis, Raffaele Gaetano, Georgios Schoretsanitis, Giuseppe Verde, Cesare Anthony Oliveti, John M Kane, Cristina Segura-Garcia & Pasquale De Fazio. (2021) Clozapine Management in Schizophrenia Inpatients: A 5-Year Prospective Observational Study of Its Safety and Tolerability Profile. Neuropsychiatric Disease and Treatment 17, pages 2141-2150.
Read now
Renato de Filippis, Pau Soldevila-Matías, Pasquale De Fazio, Daniel Guinart, Inmaculada Fuentes-Durá, Jose M. Rubio, John M. Kane & Georgios Schoretsanitis. (2020) Clozapine-related drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a systematic review. Expert Review of Clinical Pharmacology 13:8, pages 875-883.
Read now
Brianna L Combs & Arthur G Cox. (2017) Update on the treatment of Parkinson’s disease psychosis: role of pimavanserin. Neuropsychiatric Disease and Treatment 13, pages 737-744.
Read now
L. Orsolini, C. Tomasetti, A. Valchera, R. Vecchiotti, I. Matarazzo, F. Vellante, F. Iasevoli, E. F. Buonaguro, M. Fornaro, A. L. C. Fiengo, G. Martinotti, M. Mazza, G. Perna, A. Carano, A. De Bartolomeis, M. Di Giannantonio & D. De Berardis. (2016) An update of safety of clinically used atypical antipsychotics. Expert Opinion on Drug Safety 15:10, pages 1329-1347.
Read now
G. Remington, J. Lee, O. Agid, H. Takeuchi, G. Foussias, M. Hahn, G. Fervaha, L. Burton & V. Powell. (2016) Clozapine’s critical role in treatment resistant schizophrenia: ensuring both safety and use. Expert Opinion on Drug Safety 15:9, pages 1193-1203.
Read now
Antonio AT Chuh. (2015) Nomenclature of drug-induced pityriasis rosea-like rashes. Neuropsychiatric Disease and Treatment 11, pages 2547-2549.
Read now

Articles from other publishers (44)

Luyao Cai, Guanjie Chen, Haichen Yang & Yuanhan Bai. (2023) Efficacy and safety profiles of mood stabilizers and antipsychotics for bipolar depression: a systematic review. International Clinical Psychopharmacology 38:4, pages 249-260.
Crossref
Catherine W. Bennett, Lauren Gensler & David R. Goldsmith. (2022) Antipsychotics and Medical Comorbidity: A Retrospective Study in an Urban Outpatient Psychiatry Clinic. Community Mental Health Journal 59:4, pages 641-653.
Crossref
Caroline Fenton & Connie Kang. (2023) Clozapine is the approved option in treatment-resistant schizophrenia and requires careful management. Drugs & Therapy Perspectives 39:3, pages 107-113.
Crossref
Andrea Aguglia, Valentina Maria Parisi, Gabriele Arduino, Andrea Amerio, Alessandra Costanza, Gianluca Serafini & Mario Amore. (2023) Clozapine in a Young Female with Drug-Resistant Schizophrenia: A Case Report of Development of Serositis. CNS & Neurological Disorders - Drug Targets 22:2, pages 313-316.
Crossref
Mishal Qubad & Robert A. Bittner. (2023) Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia. Therapeutic Advances in Psychopharmacology 13, pages 204512532311581.
Crossref
Diane RheeMorgan JonesKate M. MitchellJacqueline SegalTimothy RiceBarbara J. Coffey. (2022) Clozapine and Constipation: Considerations in an Obese Adolescent Girl. Journal of Child and Adolescent Psychopharmacology 32:10, pages 543-547.
Crossref
Nosa Godwin Igbinomwanhia, James MacCabe, David M. Taylor & Maria C. Lobo. (2022) Clozapine-induced diarrhoea: A case report of an unusual adverse reaction. Psychiatry Research Case Reports 1:2, pages 100070.
Crossref
George D. Price, Michael V. Heinz, Matthew D. Nemesure, Jason McFadden & Nicholas C. Jacobson. (2022) Predicting symptom response and engagement in a digital intervention among individuals with schizophrenia and related psychoses. Frontiers in Psychiatry 13.
Crossref
Sung Min Ma, Junghyun Lim, Chunsu Jiang & Luminita Luca. (2022) Esophagitis after Clozapine Use in a 61-Year-Old Woman with Refractory Schizophrenia. Case Reports in Psychiatry 2022, pages 1-4.
Crossref
Nancy Monroy-Jaramillo, José Jaime Martínez-Magaña, Blanca Estela Pérez-Aldana, Alberto Ortega-Vázquez, Janitza Montalvo-Ortiz & Marisol López-López. (2022) The role of alcohol intake in the pharmacogenetics of treatment with clozapine. Pharmacogenomics 23:6, pages 371-392.
Crossref
Alexander Panickacheril John, Sally Burrows, Susanne Stanley, Cherry Acabo, Gordon Shymko, Aleksandra Jaworska & Ajay Velayudhan. (2022) Demographic and clinical characteristics of patients who recommence clozapine following therapy interruptions. Acta Psychiatrica Scandinavica 145:3, pages 293-300.
Crossref
Vesna Mijatović-JovinM.M., Nataša Perković-VukčevićR.R., Gordana Vuković-ErcegovićN.N., Snežana ĐorđevićB.B., Slavica VučinićS.S., Zoran ŠegrtP.P., Bela KolaršŠ.Š. & Jasmina Jović-StošićV.V.. (2022) Is clozapine to blame for delayed Ogilvie syndrome and gastrointestinal bleeding in overdose settings?. Hospital Pharmacology - International Multidisciplinary Journal 9:3, pages 1196-1202.
Crossref
José Fidel Baizabal-Carvallo & Joseph Jankovic. 2022. The Neurobiology of the Gilles De La Tourette Syndrome and Chronic Tics - Part B. The Neurobiology of the Gilles De La Tourette Syndrome and Chronic Tics - Part B 163 201 .
David M. Taylor, Thomas R. E. Barnes & Allan H. Young. 2021. The Maudsley Prescribing Guidelines in Psychiatry. The Maudsley Prescribing Guidelines in Psychiatry 1 224 .
Y. W. Francis Lam. (2021) Association of clozapine metabolism and neutropenia. The Brown University Psychopharmacology Update 32:9, pages 2-3.
Crossref
Elisa Pallares Vela, Prashil Dave & Ivan Cancarevic. (2021) Clozapine-Related Thromboembolic Events. Cureus.
Crossref
Alberto Ortega‐Vázquez, Yerye G. Mayen‐Lobo, David J. Dávila‐Ortiz de Montellano, Luis Tristán‐López, Carlos L. Aviña‐Cervantes, Camilo Ríos, Marisol López‐López & Nancy Monroy‐Jaramillo. (2020) Alcohol intake potentiates clozapine adverse effects associated to CYP1A2 * 1C in patients with refractory psychosis . Drug Development Research 82:5, pages 685-694.
Crossref
Amna Ramzan, Ruchi Aggarwal & Fariha Jamal. (2021) Novel case of Parkinson’s disease and schizophrenia: challenges in the management. BMJ Case Reports 14:7, pages e244028.
Crossref
Isabella R. Willcocks, Sophie E. Legge, Mariana Nalmpanti, Lucy Mazzeo, Adrian King, John Jansen, Marinka Helthuis, Michael J. Owen, Michael C. O’Donovan, James T. R. Walters & Antonio F. Pardiñas. (2021) Clozapine Metabolism is Associated With Absolute Neutrophil Count in Individuals With Treatment-Resistant Schizophrenia. Frontiers in Pharmacology 12.
Crossref
Ehtesham Iqbal, Risha Govind, Alvin Romero, Olubanke Dzahini, Matthew Broadbent, Robert Stewart, Tanya Smith, Chi-Hun Kim, Nomi Werbeloff, James H. MacCabe, Richard J. B. Dobson & Zina M. Ibrahim. (2020) The side effect profile of Clozapine in real world data of three large mental health hospitals. PLOS ONE 15:12, pages e0243437.
Crossref
Ishwary Damodaran, Koh Ong Hui, Amer Siddiq Amer Nordin, Anne Yee, Jesjeet Singh Gill, Benedict Francis, Fatin Liyana Azhar & Ahmad Hatim Sulaiman. (2020) An Open-Label, Head to Head Comparison Study between Prucalopride and Lactulose for Clozapine Induced Constipation in Patients with Treatment Resistant Schizophrenia. Healthcare 8:4, pages 533.
Crossref
Sema Baykara, Pınar Gündoğan Bozdağ, Murat Baykara & Mustafa Nuray Namlı. (2020) Evaluation of arterial stiffness in patients with schizophrenia. Journal of Clinical Neuroscience 79, pages 149-153.
Crossref
Punya Suvarna, Manasa N. Kayarkatte, Shrutakirthi D. Shenoi & Padmapriya Jaiprakash. (2020) A rare case of clozapine‐induced symmetrical drug‐related intertriginous and flexural exanthema with vasculitis‐like lesions. Contact Dermatitis 82:5, pages 318-320.
Crossref
Yuanhan Bai, Guanjie Chen, Haichen Yang & Keming Gao. (2020) Do Asian and North American patients with bipolar disorder have similar efficacy, tolerability, and safety profile during clinical trials with atypical antipsychotics?. Journal of Affective Disorders 261, pages 259-270.
Crossref
Jonathan M. Meyer & Stephen M. Stahl. 2021. The Clozapine Handbook. The Clozapine Handbook 172 189 .
Ziga Vodusek, Paul Feuerstadt & Lawrence J. Brandt. (2019) Review article: the pharmacological causes of colon ischaemia. Alimentary Pharmacology & Therapeutics 49:1, pages 51-63.
Crossref
Niku Dhillon & Reinhard Heun. (2018) Nocturnal Enuresis is an Under-recognised Side Effect of Clozapine: Results of a Systematic Review. Global Psychiatry 2:1, pages 21-30.
Crossref
Alexander Panickacheril John, Elvin Kay Fon Ko & Arun Dominic. (2018) Delayed Initiation of Clozapine Continues to Be a Substantial Clinical Concern. The Canadian Journal of Psychiatry 63:8, pages 526-531.
Crossref
Koraliya Todorova-Nenova. (2018) Transient parotitis in the course of clozapine treatment: a case report and review of the literature. Scripta Scientifica Medica 50:2, pages 47.
Crossref
N. H. Gonsai, V. H. Amin, C. G. Mendpara, R. Speth & G. M. Hale. (2018) Effects of dopamine receptor antagonist antipsychotic therapy on blood pressure. Journal of Clinical Pharmacy and Therapeutics 43:1, pages 1-7.
Crossref
Johannes Zeiler. (2018) Clozapin-induzierte KolitisClozapine-induced Colitis. psychopraxis. neuropraxis.
Crossref
Ronald J. Gurrera & Nicole L. Perry. 2018. Military and Veteran Mental Health. Military and Veteran Mental Health 335 372 .
Marta Miarons, Christopher Cabib, Francisco Javier Barón & Laia Rofes. (2017) Evidence and decision algorithm for the withdrawal of antipsychotic treatment in the elderly with dementia and neuropsychiatric symptoms. European Journal of Clinical Pharmacology 73:11, pages 1389-1398.
Crossref
Elias Begas, Andreas Tsakalof, Efthimios Dardiotis, Georgios Emmanouil Vatidis, Evangelos Kouvaras & Eftihia Konstadinos Asprodini. (2017) Development and validation of a reversed-phase HPLC method for licarbazepine monitoring in serum of patients under oxcarbazepine treatment. Biomedical Chromatography 31:9, pages e3950.
Crossref
Bang Nguyen, Charles Du, Tarun Bastiampillai, Rohan Dhillon & Prashant Tibrewal. (2017) Successful clozapine re-challenge following myocarditis. Australasian Psychiatry 25:4, pages 385-386.
Crossref
Haifa Hassine, Uta Ouali, Abdelhafidh Ouertani, Rabaa Jomli & Fethi Nacef. (2017) Clozapine-induced DRESS syndrome with multiple and rare organ involvement. Asian Journal of Psychiatry 28, pages 146-147.
Crossref
Irosh Fernando, Frans Henskens & Masoud Talebian. (2016) Evaluating complex medical treatment options: a case report. Australasian Psychiatry 25:1, pages 66-68.
Crossref
Peter Falkai, Rebecca Schennach, Tania Lincoln, Annette Schaub & Alkomiet Hasan. 2017. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie 1583 1674 .
Adam J. Prus, Laura E. Wise, Alan L. Pehrson, Scott D. Philibin, Benny Bang-Andersen, Jørn Arnt & Joseph H. Porter. (2016) Discriminative stimulus properties of 1.25 mg/kg clozapine in rats: Mediation by serotonin 5-HT 2 and dopamine D 4 receptors. Brain Research 1648, pages 298-305.
Crossref
Alkomiet Hasan. (2016) Clozapine-induced Gastrointestinal Hypomotility — New Objective Evidence for an Underestimated Side-effect. EBioMedicine 5, pages 12-13.
Crossref
Fabienne Foufelle & Bernard Fromenty. (2016) Role of endoplasmic reticulum stress in drug‐induced toxicity. Pharmacology Research & Perspectives 4:1.
Crossref
P. Chue & J. Chue. 2016. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions 35 54 .
Peter Falkai, Rebecca Schennach, Tania Lincoln, Annette Schaub & Alkomiet Hasan. 2016. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie 1 92 .
Jenny Paola Berrío Sánchez & Bart A. Ellenbroek. 2017. Non-medical and illicit use of psychoactive drugs. Non-medical and illicit use of psychoactive drugs 1 16 .

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.